A new article covering the sharing of genomic data across international borders by Professor Jacob Sherkow has been published by the journal International Data Privacy Law. “A sociotechnical approach to genomic data privacy: a comparative analysis” examines new technology designed to process genomic data within a secure computingenvironment that can comply with and align European […]
Professor Jacob Sherkow delivered his lecture, “What’s the Skinny? Drug Labels and Patent Infringement,” at Chicago-Kent College of Law on Tuesday, October 28. The event focused on the role of drug labeling in pharmaceutical patent litigation and included discussion of the pending Supreme Court cert petition in Hikma v. Amarin, on which the Supreme Court […]
On October 27, Professor Jacob Sherkow will be speaking at the Intellectual Property Workshop at Michigan Law School. He will be presenting a paper on the law of inducement in the pharmaceutical patent infringement cases, which is forthcoming in the Stanford Law Review. Event details are available from the University of Michigan Law School.
Professor Jacob Sherkow has published “A ‘Bare Hope of A Result’: The Second CRISPR Patent Appeal” in The CRISPR Journal. In the article, Sherkow provides an overview of the dispute to date, reviews the Federal Circuit’s recent opinion, and provides a critique of its analysis. Read the full article.
In an analysis of a brief expected to be filed in the fall, the Patently-O blog cites the work of Professor Jacob Sherkow extensively in examining the ‘label-plus’ theory of inducement. This framework establishes that a generic drug’s label by itself cannot violate patent protections because of a congressionally authorized regulatory scheme. Sherkow’s work, in […]
In June, Professor Jacob Sherkow traveled to Denmark to present his work, “Patent Eligibility, Secure Computing, and Genomic Data Sharing,” at the ATRIP Congress at the University of Copenhagen. His presentation took place on Monday, June 23, as part of the Intellectual Property & Justice: Balancing Frameworks in Patent Law portion of the conference. Learn […]
Polygenic testing startups offer consumers the chance of a “superbaby” by screening for genetic disorders and allowing parents to select certain embryos for fertilization; however, the ethics and the science of this practice are very controversial. Speaking to The San Francisco Standard, Professor Jacob Sherkow added his expertise on the issue. “[These companies] claim to […]
Professor Jacob Sherkow recently had the chance to present his research, “A Sociotechnical Approach to Genomic Data Security: A Comparative Legal Analysis,” to the Law, Medicine and Life Sciences group at the University of Cambridge Faculty of Law. In addition to his position at the College of Law, where he serves as director of the […]
The US Court of Appeals for the Federal Circuit ruled in May that the key patents on what many consider the defining biotechnology invention of the 21st century should be reconsidered. Jennifer Doudna and Emmanuelle Charpentier shared a 2020 Nobel Prize for developing the versatile gene-editing system CRISPR; however, the key patent rights were granted Feng Zhang […]
Colossal Biosciences is making headlines with its bold initiative to bring back the woolly mammoth, but the venture raises significant ethical and legal questions. Professor Jacob Sherkow is quoted in a new article from the MIT Technology Review about the complexities surrounding intellectual property in de-extinction efforts. He notes that while natural animals cannot be […]